No. 18-388

Nigel Parker, et al. v. Andrei Iancu, Under Secretary of Commerce for Intellectual Property and Director, Patent and Trademark Office

Lower Court: Federal Circuit
Docketed: 2018-09-26
Status: Denied
Type: Paid
Response Waived
Tags: 5-usc-706(2)(e) administrative-law administrative-procedure agency-action agency-overreach arbitrary-and-capricious patent patent-law patent-office patent-office-rejection publication publication-standard publication-under-35-usc-102(b) record-evidence substantial-evidence
Key Terms:
AdministrativeLaw Patent Trademark
Latest Conference: 2018-11-02
Question Presented (AI Summary)

Whether the substantial' evidence required to support agency action under 5 U.S.C. § 706(2)(E) must be evidence of record?

Question Presented (from Petition)

Question Presented In Dickinson v. Zurko, 527 U.S. 150 (1999), this Court held that The United States Patent Office must support rejection with substantial evidence. See Dickinson at 152, citing 5 U.S.C. § 706(2)(E). In the instant case, The Patent Office rejects Petitioners’ patent claims based on either of two alleged antedating publications. Neither document, however, is of record. This appeal thus raises simple yet fundamental questions of agency overreach: Whether the “substantial” evidence required to support agency action under 5 U.S.C. § 706(2)(E) must be evidence of record? Whether agency rejection is “arbitrary” or “capricious” under 5 U.S.C. § 706(2)(A) if supported only by alleged evidence which is not of record and which the agency has not in fact considered? Whether a document which is not publicly available is a “publication” under 35 U.S.C. § 102(b)? il Rule 14(b) Statement A list of all

Docket Entries

2018-11-05
Petition DENIED.
2018-10-17
DISTRIBUTED for Conference of 11/2/2018.
2018-10-09
Waiver of right of respondent Andrei Iancu to respond filed.
2018-09-24
Petition for a writ of certiorari filed. (Response due October 26, 2018)

Attorneys

Andrei Iancu
Noel J. FranciscoSolicitor General, Respondent
Noel J. FranciscoSolicitor General, Respondent
Nigel Parker, et al.
J. Mark PohlPharmaceutical Patent Attorneys LLC, Pohls & Assoc, Petitioner
J. Mark PohlPharmaceutical Patent Attorneys LLC, Pohls & Assoc, Petitioner